Background Emerging data suggest that Hispanic patients with pulmonary arterial
hypertension (PAH) exhibit improved survival rates compared to individuals of other …

This study explores the racial and ethnic differences in presentation, severity, and treatment
of patients with pulmonary arterial hypertension (PAH) in a large multicenter registry. African …

BACKGROUND Prior research has suggested that the prevalence and outcomes of
pulmonary arterial hypertension (PAH) may vary by race or ethnicity. However, these studies …

Rationale: Lower socioeconomic status (SES) confers a heightened risk of common
cardiovascular and pulmonary diseases and increased mortality. The association of SES …

Pulmonary arterial hypertension (PAH) is a cardiovascular disease with high mortality rate.
Current guidelines propose initiation and escalation of PAH‐targeted treatment based on a …

Rationale: There is a noticeable underrepresentation of minorities in clinical trials and
registries in pulmonary arterial hypertension (PAH). Prior studies evaluating the association …

Background Contemporary patients with pulmonary arterial hypertension (PAH) are older
and exhibit cardiovascular and/or lung comorbidities. Such patients have typically been …

Background REVEAL (The Registry to Evaluate Early and Long-term Pulmonary Arterial
Hypertension Disease Management) provides current demographics of patients with group …

It is widely known that the incidence of pulmonary arterial hypertension (PAH) is higher in
female, whereas prognosis is poorer in male patients. However, sex differences in …

Background In recent years, the population of patients with pulmonary arterial hypertension
(PAH) has changed dramatically, including more advanced age at diagnosis. We …